 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Integrase Inhibitors
Integrase Inhibitors in Development
- Cross-Resistance Between Integrase Inhibitors Looks Likely (June 12-16, 2007)
From National AIDS Treatment Advocacy Project - Another Integrase Inhibitor -- Elvitegravir (GS-9137) -- Progresses in Development (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Understanding and Inhibiting Integrase in the Treatment of HIV Disease (November 2006)
In The PRN Notebook - Integrase Inhibitors: The Next Wave? (Spring 2006)
A quick look at MK-518 and GS-9137.
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - Integrase Inhibitors in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body - Anti-HIV Pipeline: Spotlight on Integrase Inhibitors (July 2004)
To read PDF, click here
In Project Inform Perspective, from Project Inform - New Targets Bring New Challenges (March 2002)
A closer look at integrase and entry inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis - S-1360: In Vitro Activity of a New HIV-1 Integrase Inhibitor in Clinical Development (February 25, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |